Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-08-08
2009-10-20
Szperka, Michael (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C530S328000
Reexamination Certificate
active
07604955
ABSTRACT:
The present invention concerns the prophylaxis or therapy of immunoglobulin E-mediated disease conditions. The present invention discloses methods for identifying peptides that induce a cytotoxic T-lymphocyte response against immunoglobulin E. The present invention further discloses compositions that are able to elicit in a mammal a cytotoxic T-lymphocyte response to naturally processed and presented immunoglobulin E peptides, and methods for their use.
REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5028592 (1991-07-01), Lipton
patent: 5180805 (1993-01-01), Gould et al.
patent: 5254671 (1993-10-01), Chang
patent: 5428133 (1995-06-01), Chang
patent: 5583202 (1996-12-01), Zanetti
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5629415 (1997-05-01), Hollis
patent: 5653980 (1997-08-01), Hellman
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5846946 (1998-12-01), Huebner et al.
patent: 5910488 (1999-06-01), Nabel et al.
patent: 5955076 (1999-09-01), Stanworth et al.
patent: 6025485 (2000-02-01), Kamb et al.
patent: 6214804 (2001-04-01), Felgner et al.
patent: 6258549 (2001-07-01), Auer et al.
patent: 6268411 (2001-07-01), Schneck et al.
patent: 6299875 (2001-10-01), Caplan
patent: 6342220 (2002-01-01), Adams et al.
patent: 6346249 (2002-02-01), Barbas et al.
patent: 6355619 (2002-03-01), Miller et al.
patent: 6384018 (2002-05-01), Content et al.
patent: 6406706 (2002-06-01), Davis et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 2002/0012909 (2002-01-01), Plaksin
patent: 2004/0156838 (2004-08-01), Klysner et al.
patent: WO 95/26365 (1995-10-01), None
patent: WO 96/12740 (1996-05-01), None
patent: WO 97/31948 (1997-09-01), None
patent: WO 00/20027 (2000-04-01), None
patent: WO 00/20574 (2000-04-01), None
patent: WO 00/26246 (2000-05-01), None
patent: WO 00/63252 (2000-10-01), None
patent: WO 01/68861 (2001-09-01), None
patent: WO 01/69253 (2001-09-01), None
patent: WO 02/20038 (2002-03-01), None
patent: WO 02/26781 (2002-04-01), None
patent: WO 02/34287 (2002-05-01), None
Stuber et al., “Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading defficient cells” Eur J Immunol (1992) 22:2697-2703.
Chen, S S. “Mechanisms of IgE tolerance: dual regulatory T cell lesions in perinatal IgE tolerance” Eur J Immunol (1991) 21:2461-2467.
De Panfilis, G. “CD8+ cytolytic T lymphocytes and the skin” Exp Dermatol (1998) 7:121-131.
Steinbrink et al., Blood, 2002, 99:2468-2476.
Janeway et al., Immunobiology, 3rdedition, 1997, Garland Press, pp. 4:2-4:9.
Abedi et al., 1998, Nucleic Acids Res., 26:623.
Achatz et al., 1997, Science, 276:409.
Andersen et al., 2000, Tissue Antigens, 55:519.
Batista et al., 1995, J. Immunol., 154:209.
Bhardwaj, 2001, Trends Mol. Med., 7:388.
Billetta et al., 1991, Proc. Natl. Acad. Sci., 88:4713.
Billetta et al., 1995, Eur. J. Immunol., 25:776.
Billetta, 1992, Immunomethods, 1:41.
Brusic et al., 2002, Immunol. Cell Biol., 80:280.
Carreno and Collins, 2002, Annu. Rev. Immunol., 20:29.
Chang, 2000, Nature Biotech, 18:157.
Chen, 1990, J. Immunol. Meth., 135:129.
Christmann et al., 1999, Protein Eng., 12:797.
Christmann et al., 2001, J. Immunol. Methods, 257:163.
Cohen et al., 1998, FASEB J., 12:1611.
Come et al., 1997, J. Clin. Inv., 99:879.
Crameri et al., 1996, Nature Biotech., 14:315.
De Bruijn, 1991, Eur. J. Immunol., 21:2963.
Falk et al., 1991, Nature, 351:290.
Felgner et al., 1987, Proc. Natl. Acad. Sci., 84:7413.
Frauwirth and Thompson, 2002, J. Clin. Invest., 109:295.
Garman et al., 2000, Nature, 406:259.
Gerloni et al., 1999, J. Immunol., 162:3782.
Gunneriusson et al., 1999, Appl. Env. Microbiol., 65:4134.
Gurunathan et al., 2000, Annu. Rev. Immunol.,18:927.
He, 1999, J. Immunol. Methods, 231:105.
Helm et al., 1988, Nature, 331:180.
Hoerr et al., 2000, Eur. J. Immunol., 30:1.
Inaba, 1990, J. Exp. Med., 172:631.
Jerne, 1993, Scan. J. Immunol., 38:1.
Jung et al., 1993, Science, 259:984.
Katona et al., 1991, J. Immunol,. 146:4215.
Klinman et al., 1999, Vaccine, 17:19.
Liu, 1980, J. Immunol., 124:2728.
Mayordomo et al., 1997, Stem Cells, 15:94.
Milgrom et al., 1999, N. Engl. J. Med., 341:1966.
Minev et al., 2000, Proc. Natl. Acad. Sci., 97:4796.
Mössner and Plückthun, 2001, Chimia, 55:324.
Neuberger, 1995, Nature, 314:268.
Oettgen et al., 1994, Nature, 370:367.
Pamer and Cresswell, 1998, Annu. Rev. Immunol., 16:323.
Peng et al., 1992, J. Immunol., 148:129.
Phizicky and Fields, 1995, Microbiol. Rev., 59:94.
Samulski et al., 1989, J. Virol., 63:3822.
Schaffitzel et al., 1999, J. Immunol. Methods, 231:119.
Scheerlinck, 2001, Vaccine, 19:2647.
Schoenberger et al., 1998, Nature, 393:480.
Schueler-Furman et al., 2000, Protein Sci., 9:1838.
Shastri et al., 2002, Annu. Rev. Immunol., 20:463.
Skerra, 2000, J. Mol. Recognit., 13:167.
Smith, 1985, Science, 228:1315.
Somia et al., 1999 Nature Biotechnol., 17:224.
Steinman and Pope, 2002, J. Clin. Invest., 109:1519.
Sun et al., 1991, J. Immunol., 146,199.
Theobald et al., 1997, J. Exp Med., 185:833.
Tsien, 1998, Annu. Rev. Biochem., 67:509.
Vogel et al., 2000, J. Mol. Biol., 298:729.
Wang et al., 1996, Eur. J. Immunol., 26:1043.
Wilson et al., 2001, Proc. Natl. Acad. Sci., 98:3750.
Wittrup, 2001, Curr. Opin. Biotechnol., 12:395.
Yeung and Wittrup, 2002, Biotechnol. Prog., 18:212.
Ying et al., 1999, Nature Med., 5:823.
Zhang at al., 1992, J. Exp. Med., 176:233.
Zhang et al., 1994, J. Biol. Chem., 269:456.
Jin, X, et al., “Indentification of Subdominant Cytotoxic T Lymphocyte . . . ” AIDS Res. Human Retroviruses, 16:67-76 (2000).
Aveskogh, M, et al., “Evidence for an early appearance fo modern post-switch isotyes in mammalian evolution . . . ” Eur. J. Immunol., 28:2738-50 (1998).
Paliard, X, et al., “Induction of Herper Simplex Virus gB-Specific Cytotoxic T Lymphocytes in TAP1-Deficient Mice . . . ” Virology, 282:56-64 (2001).
Macary, P.A., et al., “Ovalbumin-Specific, MHC Class I-Restricted . . . ” J. Immunology, 160:580-7 (1998).
Stevens, J, et al., “Peptide length preferences for rat and mouse MHC class I molecules using random . . . ” Eur. J. Immunol., 28:1272-9 (1998).
Barankiewicz Theresa J.
Chen Swey-Shen Alex
Chen Zhong
Yang Yong-Min
Chen Swey-Shen Alex
Szperka Michael
LandOfFree
Immunoglobulin E vaccines and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoglobulin E vaccines and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoglobulin E vaccines and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092601